摘要
目的:研究治疗盆腔炎采用康妇消炎栓联合盐酸莫莎星的疗效。方法选取2013年12月~2014年12月我院收治的43例盆腔炎患者,随机分为甲组23例和乙组20例,甲组给予康妇消炎栓联合盐酸莫西沙星药物,乙组给予单纯康妇消炎栓药物,观察两组患者的治疗效果。结果甲组患者治疗好转率为95.7%(22/23)、不良反应的发生率8.7%(2/23)、复发率为4.3%,乙组患者治疗好转率为80%(16/20)、不良反应的发生率25%(5/20)、复发率为15%,两组比较差异有统计学意义(P〈0.05)。结论康妇消炎栓联合盐酸莫莎星治疗盆腔炎的效果显著,可以有效提高患者的治愈率,提高女性患者的生活质量。
Objective To evaluate the clinical efficacy of kang fu antiphlogistic suppository combined with hydrochloride moxifloxacin in treatment of pelvic inflammatory disease. Methods We chose 43 patients of pelvic inflammatory disease who were treated in hospital from December 2013 to December 2014,and separated them into two groups at random with 23 patients in group A and 20 patients in group B. Patients in group A were given kang fu antiphlogistic suppository combined with hydrochloride moxifloxacin treatment;while patients in group B were given kang fu antiphlogistic suppository treatment only;and then compared treatment effects between two groups. Results Patients’treatment improvement rate in group A was up to 95.7%(22/23),side-effect incidence was 8.7%(2/23)and il ness reoccurrence rate was 4.3%;while patients’treatment improvement rate in control group was up to 80%(16/20),side-effect incidence was 25%(5/20)and il ness reoccurrence rate was 15%;there was a treatment differential between two groups and such a differential had statistic value(P〈0.05). Conclusion Kang fu antiphlogistic suppository combined with hydrochloride moxifloxacin is of efficacy in treatment of pelvic inflammatory disease;it is conducive to increasing treatment efficacy and improving women patients’quality of life;thus,such a treatment method is quite worthwhile to be promoted and applied clinical y.
出处
《中国卫生标准管理》
2015年第11期99-100,共2页
China Health Standard Management
关键词
康妇消炎栓
盐酸莫莎星
盆腔炎
Kang fu antiphlogistic suppository
Hydrochloride moxifloxacin
Pelvic inflammatory disease